Home›Companies›Biotech & Pharma›Evergreen Theragnostics

Evergreen Theragnostics Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 18, 2023·Suggest an edit

About Evergreen Theragnostics

Evergreen Theragnostics is a private company based in Springfield, New Jersey, incorporated in 2019 in Delaware. It has reported $34,913,589 raised in two offerings on Form D since June 2020. Its chief executive is James Cook.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 15, 2022Aug 18, 2023$15,461,652fully sold58$266KEquityRule 506(b)Form D ↗
Apr 27, 2020Jun 30, 2020$19,451,937of $25.0M target76$255KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$34,913,589

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Evergreen Theragnostics's Form D filed Aug 18, 2023.

SR
Sharon Roded
Director
EM
GB
Gerard Ber
Director
JC
James Cook
Chief Executive Officer and director

Earlier filings also listed Victor Paulus (director, last listed Jun 2020).

Sources

  1. SECEvergreen Theragnostics Inc. filing history